x

Emmaus Life Sciences, Inc. (OTC:EMMA)

Business/Consumer Services • Computer Services
CIK 822370
Company

Emmaus Life Sciences, Inc. engages in the discovery, development, marketing, and sale of treatments and therapies for rare and orphan diseases. It operates through the Marketing and Sales of Endari segment. The company was founded on March 20, 1987 and is headquartered in Torrance, CA.

Address
21250 Hawthorne Boulevard
Suite 800
Torrance, California 90503
Employees
55
Stock Info
Close
$0.0175
Day Range
0.0172 - 0.0172
52 Week Range
0.0001 - 0.1290
Average volume
46.51K
Short Interest
41.22K (08/15/19)
% of Float Shorted
0.12%
Market Cap
$1.1M
Revenue
$29.6M
Net Income
-$3.73M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$0.0740
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Director
Jon S. Kuwahara
Independent Director
Wei Peu Zen
Independent Director
Ian Zwicker
SEC filings
DateFormEvent
19 Nov, 2024 8-K
19 Nov, 2024 10-Q
14 Nov, 2024 NT 10-Q
6 Nov, 2024 8-K
25 Oct, 2024 8-K
9 Oct, 2024 3
4 Oct, 2024 8-K
18 Sep, 2024 4
10 Sep, 2024 10-Q
10 Sep, 2024 8-K
10 Sep, 2024 10-Q
15 Aug, 2024 NT 10-Q
17 Jul, 2024 8-K
3 Jul, 2024 10-K
3 Jul, 2024 8-K
28 May, 2024 8-K
1 Apr, 2024 NT 10-K
29 Feb, 2024 4
26 Feb, 2024 8-K
5 Feb, 2024 4
5 Feb, 2024 4
5 Feb, 2024 4
5 Feb, 2024 4
5 Feb, 2024 4
5 Feb, 2024 4
5 Feb, 2024 4
3 Jan, 2024 4/A
22 Dec, 2023 SC 13G
21 Dec, 2023 4
20 Dec, 2023 8-K
20 Dec, 2023 3/A
19 Dec, 2023 4
19 Dec, 2023 4
4 Dec, 2023 4
14 Nov, 2023 8-K
14 Nov, 2023 10-Q
4 Oct, 2023 8-K CEO Change
23 Aug, 2023 8-K
14 Aug, 2023 10-Q
14 Aug, 2023 8-K
2 Jun, 2023 4
15 May, 2023 8-K
15 May, 2023 10-Q
31 Mar, 2023 8-K
31 Mar, 2023 10-K
7 Mar, 2023 8-K
21 Feb, 2023 SC 13D/A
31 Jan, 2023 D
20 Jan, 2023 D
20 Jan, 2023 4
19 Jan, 2023 8-K
19 Jan, 2023 4/A
17 Jan, 2023 4
17 Jan, 2023 4
17 Jan, 2023 4
17 Jan, 2023 4
17 Jan, 2023 4
17 Jan, 2023 4
17 Jan, 2023 4
17 Jan, 2023 4
12 Dec, 2022 8-K
1 Dec, 2022 4
15 Nov, 2022 8-K
14 Nov, 2022 10-Q
9 Nov, 2022 SC 13D/A
3 Nov, 2022 4
31 Oct, 2022 4
31 Oct, 2022 DEF 14A
24 Oct, 2022 4
21 Oct, 2022 PRE 14A
19 Oct, 2022 4
17 Oct, 2022 4
13 Oct, 2022 4
12 Oct, 2022 4
6 Oct, 2022 3
6 Oct, 2022 8-K
6 Oct, 2022 3
30 Sep, 2022 8-K
19 Aug, 2022 8-K
15 Aug, 2022 8-K
15 Aug, 2022 10-Q
10 Aug, 2022 8-K
25 Jul, 2022 4
1 Jul, 2022 10-K/A
30 Jun, 2022 D
10 Jun, 2022 8-K CEO Change
3 Jun, 2022 4
2 Jun, 2022 4
19 May, 2022 4
13 May, 2022 10-Q
13 May, 2022 8-K
12 Apr, 2022 4
31 Mar, 2022 8-K
31 Mar, 2022 10-K
2 Mar, 2022 4
28 Feb, 2022 4
28 Feb, 2022 4
23 Feb, 2022 4
18 Feb, 2022 4
17 Feb, 2022 SC 13D/A
16 Feb, 2022 4
11 Feb, 2022 4
9 Feb, 2022 4
7 Feb, 2022 4
24 Jan, 2022 3
10 Jan, 2022 8-K
5 Jan, 2022 4
5 Jan, 2022 4
3 Jan, 2022 4
30 Dec, 2021 S-8
28 Dec, 2021 4
28 Dec, 2021 3
22 Dec, 2021 4
20 Dec, 2021 3
17 Dec, 2021 4
10 Dec, 2021 4
6 Dec, 2021 4
2 Dec, 2021 4
1 Dec, 2021 SC 13D/A
30 Nov, 2021 4
30 Nov, 2021 3
30 Nov, 2021 4
29 Nov, 2021 8-K
26 Nov, 2021 4
26 Nov, 2021 4
23 Nov, 2021 4
23 Nov, 2021 4
19 Nov, 2021 4
12 Nov, 2021 10-Q
22 Oct, 2021 4
12 Oct, 2021 DEF 14A
12 Oct, 2021 8-K
7 Oct, 2021 4
30 Sep, 2021 PRE 14A
29 Sep, 2021 4
27 Sep, 2021 4
23 Sep, 2021 4
17 Sep, 2021 4
17 Sep, 2021 4
13 Sep, 2021 4
10 Sep, 2021 4
8 Sep, 2021 4
2 Sep, 2021 4
1 Sep, 2021 10-Q
1 Sep, 2021 10-Q
27 Aug, 2021 4
26 Aug, 2021 4
26 Aug, 2021 10-Q
26 Aug, 2021 10-Q
26 Aug, 2021 10-Q
23 Aug, 2021 4
18 Aug, 2021 4
13 Aug, 2021 4
10 Aug, 2021 8-K
10 Aug, 2021 4
10 Aug, 2021 10-K/A
5 Aug, 2021 4
2 Aug, 2021 4
28 Jul, 2021 4
23 Jul, 2021 4
22 Jul, 2021 SC 13D/A
20 Jul, 2021 4
15 Jul, 2021 4
12 Jul, 2021 4
7 Jul, 2021 4
1 Jul, 2021 4
28 Jun, 2021 4
22 Jun, 2021 4
17 Jun, 2021 4
14 Jun, 2021 4
9 Jun, 2021 4
3 Jun, 2021 4
28 May, 2021 4
28 May, 2021 4
25 May, 2021 4
20 May, 2021 4
19 May, 2021 8-K
17 May, 2021 NT 10-Q
14 May, 2021 4
12 May, 2021 4
10 May, 2021 4
7 May, 2021 4
4 May, 2021 10-K
31 Mar, 2021 NT 10-K
22 Feb, 2021 8-K
16 Feb, 2021 8-K
16 Feb, 2021 D
25 Jan, 2021 10-K
Last update:2025-03-06 12:50:37.796477

Sign Up to Subscribe